Heart rate reduction: A potential target for the treatment of myocardial ischaemia

Therapie

Volumn 59, Issue 5, 2004, Pages 511-515

  Danchin, Nicolas ^a   Aly, Sidi ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Heart rate; If current; Ivabradine; Myocardial ischaemia; blockers

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DOBUTAMINE; DOPAMINE; IVABRADINE; PLACEBO; ZATEBRADINE;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CHRONOTROPISM; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; DRUG EFFICACY; EXERCISE; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART RATE VARIABILITY; HEART REHABILITATION; HUMAN; INOTROPISM; ION CURRENT; META ANALYSIS; MONKEY; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SINUS NODE; STUNNED HEART MUSCLE; TRAINING;

EID: 11144248835     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2004088     Document Type: Conference Paper

References (21)

1. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736-49
2. Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after myocardial infarction. Am J Cardiol 1990; 65: 547-53
3. Aronow WS, Ahn C, Mercando AD, et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996; 78: 1175-6
4. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180-2
5. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharmacol 1987; 10 Suppl. 2: S100-2
6. Beere PA, Glagov S, Zarins CK. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey: localization, compensatory enlargement, and the sparing effect of lowered heart rate. Arterioscler Thromb 1992; 12: 1245-53
7. Bassiouny HS, Zarins CK, Kadowaki MH, et al. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994; 19: 426-34
8. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 1990; 81: 850-9
9. Lauer MS, Okin PM, Larson MG, et al. Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996; 93: 1520-6
10. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477-82
11. Malfatto G, Facchini M, Sala L, et al. Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction. Am J Cardiol 1998; 81: 834-40
12. Hambrecht R, Walther C, Möbius-Winckler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004; 109: 1371-8
13. Marie PY, Danchin N, Branly F, et al. Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of beta-blocking antianginal medications. J Am Coll Cardiol 1999; 34: 113-21
14. Freemantle N, Cleland J, Young P, et al. Beta-blockade after myocardial infarction: systematic review and meta-regression analysis. BMJ 1999; 318: 1730-7
15. Singh BN. Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate. J Cardiovasc Pharmacol Ther 2001; 6: 313-31
16. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103: 1428-33
17. Colin P, Ghaleh B, Monnet X, et al. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003; 284: H676-82
18. Aupetit JF, Frassati D, Bui-Xuan B. et al. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Cardiovasc Res 1998; 37: 646-55
19. Classer SP, Michie DD, Thadani U, et al. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol 1997; 79: 1401-5
20. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003; 107: 817-23
21. Hanania G, Cambou JP, Gueret P, et al. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nation-wide USIC 2000 registry. Heart. In press